Tandem Diabetes Care (TNDM) Total Liabilities (2013 - 2026)

Tandem Diabetes Care's Total Liabilities history runs 14 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• Quarterly Total Liabilities rose 33.14% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 33.14% YoY) and the FY2025 annual result came in at $725.9 million, up 3.03% from the prior year.
• Total Liabilities was $1.0 billion for Q1 2026 at Tandem Diabetes Care, up from $725.9 million in the prior quarter.
• Across five years, Total Liabilities topped out at $1.0 billion in Q1 2026 and bottomed at $577.9 million in Q1 2022.
• A 5-year average of $689.7 million and a median of $698.0 million in 2024 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities soared 35.84% — and 2023, when it gained 0.03%.
• Tandem Diabetes Care's Total Liabilities stood at $612.8 million in 2022, then climbed by 4.27% to $639.0 million in 2023, then grew by 10.26% to $704.6 million in 2024, then rose by 3.03% to $725.9 million in 2025, then jumped by 40.64% to $1.0 billion in 2026.
• Business Quant data shows TNDM's Total Liabilities at $1.0 billion in Q1 2026, $725.9 million in Q4 2025, and $741.7 million in Q3 2025.